Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Mid Cap | Pharmaceuticals & Drugs
1453.50
13.20 (0.92%)
< Home < Back

Cipla’s arm completes acquisition of 100% equity stake in Actor Pharma

Date: 08-02-2024

Cipla’s wholly owned subsidiary -- Cipla Medpro South Africa has completed the acquisition of 100% equity stake in Actor Pharma, South Africa (Actor) as on February 7, 2024. Accordingly, Actor will now be a wholly owned step-down subsidiary of the Company

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.